Latest Darwin Global Management, Ltd. Stock Portfolio
$3.76Billion | No. of Holdings #5
Darwin Global Management, Ltd. Performance
2026 Q2+2.24%
YTD-9.01%
2025+134.40%
About Darwin Global Management, Ltd. and 13F Hedge Fund Stock Holdings
On 2026-08-14, the fund reported it's updated stock portfolio. In the 13F Holdings report, Darwin Global Management, Ltd. reported an equity portfolio of $3.8 Billions as of 30 Jun, 2026. <br><br> The top stock holdings of Darwin Global Management, Ltd. are RVMD, INSM, BLTE. The fund has invested 54.5% of it's portfolio in REVOLUTION MEDICINES INC and 17.9% of portfolio in INSMED INC. <br><br> The fund managers got completely rid off DIANTHUS THERAPEUTICS INC stocks. They significantly reduced their stock positions in INSMED INC (INSM) and ROIVANT SCIENCES LTD (ROIV). The fund showed a lot of confidence in some stocks as they added substantially to REVOLUTION MEDICINES INC (RVMD), ABIVAX SA and BELITE BIO INC (BLTE).
Darwin Global Management, Ltd. Equity Portfolio Value
Last Reported on: 14 Aug, 2026
$3.76Billion
as of Aug 14, 2026Darwin Global Management, Ltd. Annual Return Estimates Vs S&P 500
Our best estimate is that Darwin Global Management, Ltd. made a return of 2.24% in the last quarter. In trailing 12 months, it's portfolio return was 49.9%.
- Performance
- S&P 500
New Buys
No new stocks were added by Darwin Global Management, Ltd.
Additions
| Ticker | % Inc. |
|---|---|
| revolution medicines inc | 380 |
| abivax sa | 4.41 |
| belite bio inc | 0.65 |
Additions to existing portfolio by Darwin Global Management, Ltd.
Reductions
| Ticker | % Reduced |
|---|---|
| insmed inc | -61.73 |
| roivant sciences ltd | -0.74 |
Darwin Global Management, Ltd. reduced stake in above stock
Sold off
| Ticker | $ Sold |
|---|---|
| dianthus therapeutics inc | -1,456,600 |
Darwin Global Management, Ltd. got rid off the above stocks
Sector Distribution
Darwin Global Management, Ltd. has about 78.6% of it's holdings in Healthcare sector.
- Healthcare
- Others
| Sector | % |
|---|---|
| Healthcare | 78.6 |
| Others | 21.4 |
Market Cap. Distribution
Darwin Global Management, Ltd. has about 78.6% of it's portfolio invested in the large-cap and mega-cap stocks.
- LARGE-CAP
- UNALLOCATED
| Category | % |
|---|---|
| LARGE-CAP | 78.6 |
| UNALLOCATED | 21.4 |
Stocks belong to which Index?
About 72.4% of the stocks held by Darwin Global Management, Ltd. either belong to S&P 500 or RUSSELL 2000 index.
- RUSSELL 2000
- Others
| Index | % |
|---|---|
| RUSSELL 2000 | 72.4 |
| Others | 27.6 |
Darwin Global Management, Ltd. Holdings Map
This heatmap illustrates the top 50 positions within the fund's portfolio.
Current Stock Holdings of Darwin Global Management, Ltd.
Darwin Global Management, Ltd. has 5 stocks in it's portfolio. INSM proved to be the most loss making stock for the portfolio. RVMD was the most profitable stock for Darwin Global Management, Ltd. last quarter.
$3.76BTotal Value
6.00Positions
14 Aug, 2026Last Reported
| Expand | Holdingsorted ascending | % Portfolio | Shares Held | $ Value | % Change |
|---|---|---|---|---|---|
 BLTE Belite Bio IncBelite Bio IncBLTE | 12.14% | 3,077,220 | $456.59M 12.14% | 0.65%increased 0.65 percentadded | |
 Insmed Inc Insmed IncINSM Darwin Global Management, Ltd.'s holding in Insmed Inc over time | 17.91% | 6,431,160 | $673.60M 17.91% | 61.73%decreased 61.73 percentreduced | |
 Roivant Sciences Ltd Darwin Global Management, Ltd.'s holding in Roivant Sciences Ltd over time | 6.23% | 6,747,300 | $234.33M 6.23% | 0.74%decreased 0.74 percentreduced | |
 Revolution Medicines Inc Darwin Global Management, Ltd.'s holding in Revolution Medicines Inc over time | 54.45% | 10,629,800 | $2.05B 54.45% | 380.77%increased 380.77 percentadded | |
Sponsored Ads Abivax SaAbivax Sa | 9.26% | 3,621,580 | $348.21M 9.26% | 4.41%increased 4.41 percentadded | |
Com Dianthus Therapeutics IncDianthus Therapeutics Inc | 0% | 0.00 | $0.00 0% | 100%decreased 100 percentsold off | |